Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


20.03.2017

2 Arch Virol
1 J Gen Virol
1 JAMA
1 Lancet
2 Lancet Glob Health
1 Lancet Public Health
3 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
1 Pediatr Infect Dis J
2 Pediatrics
3 PLoS One
2 Science
14 Vaccine
1 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. SHAH MS, Ashraf A, Khan MI, Rahman M, et al
    Fowl adenovirus: history, emergence, biology and development of a vaccine against hydropericardium syndrome.
    Arch Virol. 2017 Mar 10. doi: 10.1007/s00705-017-3313.
    PubMed     Text format     Abstract available

  2. YOGISHARADHYA R, Kumar A, Ramappa R, Venkatesan G, et al
    Functional characterization of recombinant major envelope protein (rB2L) of orf virus.
    Arch Virol. 2017;162:953-962.
    PubMed     Text format     Abstract available


    J Gen Virol

  3. HAINISCH EK, Abel-Reichwald H, Shafti-Keramat S, Pratscher B, et al
    Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.
    J Gen Virol. 2017;98:230-241.
    PubMed     Text format     Abstract available


    JAMA

  4. WINSLOW RL, Milligan ID, Voysey M, Luhn K, et al
    Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year.
    JAMA. 2017;317:1075-1077.
    PubMed     Text format    


    Lancet

  5. THE LANCET
    Evaluating industry's role in vaccine access.
    Lancet. 2017;389:984.
    PubMed     Text format    


    Lancet Glob Health

  6. IVERS LC
    Vaccines plus water, sanitation, and hygiene interventions in the fight against cholera - Authors' reply.
    Lancet Glob Health. 2017;5:e395.
    PubMed     Text format    

  7. VELLEMAN Y, Wilson-Jones M
    Vaccines plus water, sanitation, and hygiene interventions in the fight against cholera.
    Lancet Glob Health. 2017;5:e394.
    PubMed     Text format    


    Lancet Public Health

  8. HODGSON D, Baguelin M, van Leeuwen E, Panovska-Griffiths J, et al
    Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis.
    Lancet Public Health. 2017;2:e74-e81.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  9. NNADI C, Damisa E, Esapa L, Braka F, et al
    Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas - Nigeria, 2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:190-193.
    PubMed     Text format     Abstract available

  10. MBAEYI C, Ryan MJ, Smith P, Mahamud A, et al
    Response to a Large Polio Outbreak in a Setting of Conflict - Middle East, 2013-2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:227-231.
    PubMed     Text format     Abstract available

  11. BOYD AT, Dombaxe D, Moreira R, Oliveira MS, et al
    Notes from the Field: Investigation of Patients Testing Positive for Yellow Fever Viral RNA After Vaccination During a Mass Yellow Fever Vaccination Campaign - Angola, 2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:282-283.
    PubMed     Text format    


    N Engl J Med

  12. BAUSCH DG
    One Step Closer to an Ebola Virus Vaccine.
    N Engl J Med. 2017;376:984-985.
    PubMed     Text format    


    Pediatr Infect Dis J

  13. GOUVEIA M, Fiorentino F, Jesus G, Costa J, et al
    Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Portugal.
    Pediatr Infect Dis J. 2017 Mar 10. doi: 10.1097/INF.0000000000001587.
    PubMed     Text format     Abstract available


    Pediatrics

  14. NAYAKWADI SINGER M, Heath C, Muinde J, Gildengorin V, et al
    Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood.
    Pediatrics. 2017 Mar 16. pii: e20162781. doi: 10.1542/peds.2016-2781.
    PubMed     Text format     Abstract available

  15. GREENHOW TL, Hung YY, Herz A
    Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines.
    Pediatrics. 2017 Mar 10. pii: e20162098. doi: 10.1542/peds.2016-2098.
    PubMed     Text format     Abstract available


    PLoS One

  16. LAURENS MB, Kouriba B, Bergmann-Leitner E, Angov E, et al
    Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
    PLoS One. 2017;12:e0173294.
    PubMed     Text format     Abstract available

  17. ESQUERRE M, Bouillette-Marussig M, Goubier A, Momot M, et al
    GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression.
    PLoS One. 2017;12:e0174038.
    PubMed     Text format     Abstract available

  18. JONES C, Sadarangani M, Lewis S, Payne I, et al
    Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.
    PLoS One. 2016;11:e0154153.
    PubMed     Text format     Abstract available


    Science

  19. HAYNES BF, Burton DR
    Developing an HIV vaccine.
    Science. 2017;355:1129-1130.
    PubMed     Text format    

  20. OSTERHOLM MT
    Ebola and Zika: Cautionary tales.
    Science. 2016;353:1073.
    PubMed     Text format    


    Vaccine

  21. GIERSING BK, Karron RA, Vekemans J, Kaslow DC, et al
    Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016.
    Vaccine. 2017 Mar 14. pii: S0264-410X(17)30293.
    PubMed     Text format     Abstract available

  22. PROBST P, Grigg JB, Wang M, Munoz E, et al
    A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30118.
    PubMed     Text format     Abstract available

  23. ALLEMANN A, Frey PM, Brugger SD, Hilty M, et al
    Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30174.
    PubMed     Text format     Abstract available

  24. LEVIN Y, Kochba E, Mani S
    Cutaneous vaccination: Briefings of the third skin vaccination summit, September 2-4, 2015, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
    Vaccine. 2017 Mar 8. pii: S0264-410X(17)30268.
    PubMed     Text format    

  25. SMITH LE, Webster RK, Weinman J, Amlot R, et al
    Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects: A cross-sectional survey in England.
    Vaccine. 2017 Feb 24. pii: S0264-410X(17)30225.
    PubMed     Text format     Abstract available

  26. UI H, Yamayoshi S, Uraki R, Kiso M, et al
    Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30244.
    PubMed     Text format     Abstract available

  27. DALEY MF, Glanz JM, Newcomer SR, Jackson ML, et al
    Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30271.
    PubMed     Text format     Abstract available

  28. KURZ X, Bauchau V, Mahy P, Glismann S, et al
    The ADVANCE Code of Conduct for collaborative vaccine studies.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30242.
    PubMed     Text format     Abstract available

  29. FORD T, Wenden C, Mbekeani A, Dally L, et al
    Cryopreservation-related loss of antigen-specific IFNgamma producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30241.
    PubMed     Text format     Abstract available

  30. MOSNIER A, Daviaud I, Caini S, Berche H, et al
    Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003-2014.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30292.
    PubMed     Text format     Abstract available

  31. VENTURAS C, Umeh K
    Health professional feedback on HPV vaccination roll-out in a developing country.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30265.
    PubMed     Text format     Abstract available

  32. MADAN A, Ferguson M, Rheault P, Seiden D, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30270.
    PubMed     Text format     Abstract available

  33. LANSBURY LE, Smith S, Beyer W, Karamehic E, et al
    Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis.
    Vaccine. 2017 Mar 14. pii: S0264-410X(17)30272.
    PubMed     Text format     Abstract available

  34. TREANOR JT, Albano FR, Sawlwin DC, Graves Jones A, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30291.
    PubMed     Text format     Abstract available


    Wkly Epidemiol Rec


  35. Recommended composition of influenza virus vaccines for use in the 2017-2018 northern hemisphere influenza season.
    Wkly Epidemiol Rec. 2017;92:117-28.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: